Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
QMRO Home
Wolfson Institute of Preventive Medicine
Centre for Cancer Prevention
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
QMRO Home
Wolfson Institute of Preventive Medicine
Centre for Cancer Prevention
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
View/
Open
Accepted version (94Kb)
Supplementary Material (128.5Kb)
Volume
158
Pagination
591 - 596
DOI
10.1007/s10549-016-3885-x
Journal
BREAST CANCER RESEARCH AND TREATMENT
Issue
3
ISSN
0167-6806
Metadata
Show full item record
Authors
Brentnall, AR; Cuzick, J; Byers, H; Segal, C; Reuter, C; Detre, S; Sestak, I; Howell, A; Powles, TJ; Newman, WG
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15403
Collections
Centre for Cancer Prevention
[858]
Licence information
The final publication is available at Springer via http://dx.doi.org/10.1007/s10549-016-3885-x
Copyright statements
(c) Springer Science+Business Media New York 2016